Neuroblastoma Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neuroblastoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroblastoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroblastoma Treatment Overall Market Size
2.1 Global Neuroblastoma Treatment Market Size: 2023 VS 2030
2.2 Global Neuroblastoma Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroblastoma Treatment Players in Global Market
3.2 Top Global Neuroblastoma Treatment Companies Ranked by Revenue
3.3 Global Neuroblastoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Neuroblastoma Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neuroblastoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroblastoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Neuroblastoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuroblastoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroblastoma Treatment Market Size Markets, 2023 & 2030
4.1.2 Combination Chemotherapy
4.1.3 Monoclonal Antibody Therapy
4.1.4 Vaccine Therapy
4.1.5 Chimeric Antigen Receptor T-Cell Immunotherapy
4.1.6 Oncolytic Virus Therapy
4.2 By Type - Global Neuroblastoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Neuroblastoma Treatment Revenue, 2019-2024
4.2.2 By Type - Global Neuroblastoma Treatment Revenue, 2025-2030
4.2.3 By Type - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuroblastoma Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Neuroblastoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Neuroblastoma Treatment Revenue, 2019-2024
5.2.2 By Application - Global Neuroblastoma Treatment Revenue, 2025-2030
5.2.3 By Application - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neuroblastoma Treatment Market Size, 2023 & 2030
6.2 By Region - Global Neuroblastoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Neuroblastoma Treatment Revenue, 2019-2024
6.2.2 By Region - Global Neuroblastoma Treatment Revenue, 2025-2030
6.2.3 By Region - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neuroblastoma Treatment Revenue, 2019-2030
6.3.2 US Neuroblastoma Treatment Market Size, 2019-2030
6.3.3 Canada Neuroblastoma Treatment Market Size, 2019-2030
6.3.4 Mexico Neuroblastoma Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neuroblastoma Treatment Revenue, 2019-2030
6.4.2 Germany Neuroblastoma Treatment Market Size, 2019-2030
6.4.3 France Neuroblastoma Treatment Market Size, 2019-2030
6.4.4 U.K. Neuroblastoma Treatment Market Size, 2019-2030
6.4.5 Italy Neuroblastoma Treatment Market Size, 2019-2030
6.4.6 Russia Neuroblastoma Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Neuroblastoma Treatment Market Size, 2019-2030
6.4.8 Benelux Neuroblastoma Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neuroblastoma Treatment Revenue, 2019-2030
6.5.2 China Neuroblastoma Treatment Market Size, 2019-2030
6.5.3 Japan Neuroblastoma Treatment Market Size, 2019-2030
6.5.4 South Korea Neuroblastoma Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Neuroblastoma Treatment Market Size, 2019-2030
6.5.6 India Neuroblastoma Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neuroblastoma Treatment Revenue, 2019-2030
6.6.2 Brazil Neuroblastoma Treatment Market Size, 2019-2030
6.6.3 Argentina Neuroblastoma Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuroblastoma Treatment Revenue, 2019-2030
6.7.2 Turkey Neuroblastoma Treatment Market Size, 2019-2030
6.7.3 Israel Neuroblastoma Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Neuroblastoma Treatment Market Size, 2019-2030
6.7.5 UAE Neuroblastoma Treatment Market Size, 2019-2030
7 Neuroblastoma Treatment Companies Profiles
7.1 Seattle Children?s
7.1.1 Seattle Children?s Company Summary
7.1.2 Seattle Children?s Business Overview
7.1.3 Seattle Children?s Neuroblastoma Treatment Major Product Offerings
7.1.4 Seattle Children?s Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.1.5 Seattle Children?s Key News & Latest Developments
7.2 CureSearch
7.2.1 CureSearch Company Summary
7.2.2 CureSearch Business Overview
7.2.3 CureSearch Neuroblastoma Treatment Major Product Offerings
7.2.4 CureSearch Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.2.5 CureSearch Key News & Latest Developments
7.3 Texas Children?s
7.3.1 Texas Children?s Company Summary
7.3.2 Texas Children?s Business Overview
7.3.3 Texas Children?s Neuroblastoma Treatment Major Product Offerings
7.3.4 Texas Children?s Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.3.5 Texas Children?s Key News & Latest Developments
7.4 NANT
7.4.1 NANT Company Summary
7.4.2 NANT Business Overview
7.4.3 NANT Neuroblastoma Treatment Major Product Offerings
7.4.4 NANT Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.4.5 NANT Key News & Latest Developments
7.5 Sino Biopharmaceutical
7.5.1 Sino Biopharmaceutical Company Summary
7.5.2 Sino Biopharmaceutical Business Overview
7.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Major Product Offerings
7.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.5.5 Sino Biopharmaceutical Key News & Latest Developments
7.6 Jiangsu Hengrui Medicine Co.,Ltd.
7.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Summary
7.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
7.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Major Product Offerings
7.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Key News & Latest Developments
7.7 Fosun Pharmaceutical
7.7.1 Fosun Pharmaceutical Company Summary
7.7.2 Fosun Pharmaceutical Business Overview
7.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Major Product Offerings
7.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.7.5 Fosun Pharmaceutical Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Neuroblastoma Treatment Major Product Offerings
7.8.4 Novartis Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 Juno Therapeutics
7.9.1 Juno Therapeutics Company Summary
7.9.2 Juno Therapeutics Business Overview
7.9.3 Juno Therapeutics Neuroblastoma Treatment Major Product Offerings
7.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.9.5 Juno Therapeutics Key News & Latest Developments
7.10 Kite Pharma
7.10.1 Kite Pharma Company Summary
7.10.2 Kite Pharma Business Overview
7.10.3 Kite Pharma Neuroblastoma Treatment Major Product Offerings
7.10.4 Kite Pharma Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.10.5 Kite Pharma Key News & Latest Developments
7.11 Adaptimmune
7.11.1 Adaptimmune Company Summary
7.11.2 Adaptimmune Business Overview
7.11.3 Adaptimmune Neuroblastoma Treatment Major Product Offerings
7.11.4 Adaptimmune Neuroblastoma Treatment Revenue in Global Market (2019-2024)
7.11.5 Adaptimmune Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neuroblastoma Treatment Market Opportunities & Trends in Global Market
Table 2. Neuroblastoma Treatment Market Drivers in Global Market
Table 3. Neuroblastoma Treatment Market Restraints in Global Market
Table 4. Key Players of Neuroblastoma Treatment in Global Market
Table 5. Top Neuroblastoma Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neuroblastoma Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neuroblastoma Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neuroblastoma Treatment Product Type
Table 9. List of Global Tier 1 Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neuroblastoma Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neuroblastoma Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neuroblastoma Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neuroblastoma Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neuroblastoma Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neuroblastoma Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neuroblastoma Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neuroblastoma Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neuroblastoma Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neuroblastoma Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neuroblastoma Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neuroblastoma Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neuroblastoma Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neuroblastoma Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Seattle Children?s Company Summary
Table 31. Seattle Children?s Neuroblastoma Treatment Product Offerings
Table 32. Seattle Children?s Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Seattle Children?s Key News & Latest Developments
Table 34. CureSearch Company Summary
Table 35. CureSearch Neuroblastoma Treatment Product Offerings
Table 36. CureSearch Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. CureSearch Key News & Latest Developments
Table 38. Texas Children?s Company Summary
Table 39. Texas Children?s Neuroblastoma Treatment Product Offerings
Table 40. Texas Children?s Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Texas Children?s Key News & Latest Developments
Table 42. NANT Company Summary
Table 43. NANT Neuroblastoma Treatment Product Offerings
Table 44. NANT Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. NANT Key News & Latest Developments
Table 46. Sino Biopharmaceutical Company Summary
Table 47. Sino Biopharmaceutical Neuroblastoma Treatment Product Offerings
Table 48. Sino Biopharmaceutical Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Sino Biopharmaceutical Key News & Latest Developments
Table 50. Jiangsu Hengrui Medicine Co.,Ltd. Company Summary
Table 51. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offerings
Table 52. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Jiangsu Hengrui Medicine Co.,Ltd. Key News & Latest Developments
Table 54. Fosun Pharmaceutical Company Summary
Table 55. Fosun Pharmaceutical Neuroblastoma Treatment Product Offerings
Table 56. Fosun Pharmaceutical Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Fosun Pharmaceutical Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Neuroblastoma Treatment Product Offerings
Table 60. Novartis Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Juno Therapeutics Company Summary
Table 63. Juno Therapeutics Neuroblastoma Treatment Product Offerings
Table 64. Juno Therapeutics Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Juno Therapeutics Key News & Latest Developments
Table 66. Kite Pharma Company Summary
Table 67. Kite Pharma Neuroblastoma Treatment Product Offerings
Table 68. Kite Pharma Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Kite Pharma Key News & Latest Developments
Table 70. Adaptimmune Company Summary
Table 71. Adaptimmune Neuroblastoma Treatment Product Offerings
Table 72. Adaptimmune Neuroblastoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 73. Adaptimmune Key News & Latest Developments
List of Figures
Figure 1. Neuroblastoma Treatment Segment by Type in 2023
Figure 2. Neuroblastoma Treatment Segment by Application in 2023
Figure 3. Global Neuroblastoma Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neuroblastoma Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neuroblastoma Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2023
Figure 8. By Type - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neuroblastoma Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neuroblastoma Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 16. US Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 28. China Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neuroblastoma Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neuroblastoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Seattle Children?s Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. CureSearch Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Texas Children?s Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. NANT Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sino Biopharmaceutical Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Fosun Pharmaceutical Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Novartis Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Juno Therapeutics Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Kite Pharma Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Adaptimmune Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
